腹膜透析患者心血管并发症及其防治  

Management of cardiovascular disease in peritoneal dialysis patients

作　　者：程慧栋[1] 俞雨生[1] 

机构地区：[1]南京军区南京总医院肾脏科国家肾脏疾病临床医学研究中心全军肾脏病研究所,南京210016

出　　处：《肾脏病与透析肾移植杂志》2016年第5期479-483,共5页Chinese Journal of Nephrology,Dialysis & Transplantation

摘　　要：腹膜透析(PD)是终末期肾病患者的主要替代治疗方式之一。但近十年来的研究表明,缺血性心脏病、充血性心力衰竭和动脉粥样硬化性心脏病等心血管疾病(CVD)已成为PD患者死亡的重要危险因素。本文针对PD患者并发CVD的流行病学、发病原因、监测手段及防治做一简述。Peritoneal dialysis （PD） is one of the main replacement therapies for patients with end-stage renal disease （ESRD）. In decades, studies suggested the increasing trend of cardiovascular disease occur in patients who taking long-term PD. Cardiovascular diseases, such as ischemia cardiac disease,congestive heart failure and atherosclerotic heart disease, are the leading cause of morbility and mortality in PD patients. This article will discuss the epidemiology, monitor and prevention of CVD in PD patients.

关 键 词：腹膜透析 心血管疾病 容量超负荷 

分 类 号：R459.5[医药卫生—治疗学]